Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05877404 · ClinicalTrials.gov registry record
Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial Cancer
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- 112
- Enrollment target
NCT05877404: Clinical Trial study, sponsored by Wake Forest University Health Sciences.
NCT05877404 is a clinical trial that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 112 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05877404 was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- 112 participants
- Enrollment target
Study Summary
In order to formulate strategies to improve adherence to best practice guidelines, as well as utilization of novel therapies, investigators must understand current practice patterns surrounding tumor genetic testing in endometrial cancer. The aim is to survey a representative sample of gynecologic oncologists who belong to the society of gynecologic oncology, via an email survey, to better understand current practices surrounding tumor genetic testing as well as determine if there have been any changes to practice since the publication of recent trials on the use of immune-checkpoint inhibitors in endometrial cancer.
Primary Outcome
The primary outcome is to estimate the percentage of providers who report the use of different tumor testing strategies. Investigators will calculate the frequencies of responses to each testing strategy and then compare the percentage of physicians who choose different strategies, using a chi-square or Fisher's exact test.
Interventions
- OTHER Surveys
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2023-08-15 |
| Est. Completion | 2024-02-28 |
Why NCT05877404 stopped before completion
NCT05877404 is an observational study that tracks outcomes without assigning an intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Surveys is the first listed.
NCT05877404 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05877404 about?
NCT05877404 is a clinical study titled "Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial Cancer". In order to formulate strategies to improve adherence to best practice guidelines, as well as utilization of novel therapies, investigators must understand current practice patterns surrounding tumor genetic testing in endometrial cancer. The aim is to survey a representative sample of gynecologic o...
What is the current status of trial NCT05877404?
This trial is currently terminated. The enrollment target is 112 participants. The study started on 2023-08-15. Estimated completion is 2024-02-28.
What interventions are being tested in trial NCT05877404?
The interventions under investigation include: Surveys (OTHER).
Who is sponsoring clinical trial NCT05877404?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI